Germany - Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector
Since 2013, Germany Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector remained stable. At €0.1 Million in 2017, the country was ranked number 1 among other countries in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector. Belgium witnessed the best average annual growth at a stable, while Belgium was the worst growing country at a stable.
Loading...
| Date | Million Euros |
|---|---|
| 2017 | 0.10 |
| 2016 | 0.10 |
| 2015 | 0.10 |
| 2014 | 0.10 |
| 2013 | 0.10 |
Download all data from 2013 to 2017
How does Germany rank in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector?
| # | 2 Countries | Million Euros | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
0.10 | 2017 | +0.0 % | +0.0 % | View data |
| 1 |
#1
Germany
|
0.10 | 2017 | +0.0 % | +0.0 % | View data |